Humacyte, Inc. Appoints The Honorable Kathleen Sebelius And Dale A. Sander To Board Of Directors

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Humacyte, Inc., a pioneer in biotechnology and regenerative medicine, announced today that former U.S. Secretary of Health and Human Services, Kathleen Sebelius, and healthcare executive, Dale A. Sander have been elected to the Board of Directors effective September 1, 2015 bringing the size of the Humacyte Board to eight directors.

Suggested Articles

The ambitious target is enabled by an AI discovery platform that Healx thinks gives it a scalability that has more in common with tech than biotech.

Eli Lilly is closing down its U.K.-based Erl Wood neuroscience in Surrey, leading to cuts and relocations.

After being hailed as a near mystic when it came to stock picks, Britain’s once great oak has been cut down to a sapling as Neil Woodford gets the ax.